Richman S J, Reese R T
Agouron Institute, La Jolla, CA 92037.
Proc Natl Acad Sci U S A. 1988 Mar;85(5):1662-6. doi: 10.1073/pnas.85.5.1662.
A protein of 75 kDa is produced in large quantities by the human malarial parasite Plasmodium falciparum and is present on the surface of the merozoite, whose function is to infect erythrocytes. Based on nucleotide sequence coding for 40% of this protein, two nonoverlapping model peptides 13 and 19 residues long were synthesized, coupled to a keyhole limpet hemocyanin carrier, and used to immunize rabbits. Although both antisera had high titers of anti-peptide antibodies, only that raised against the 13-residue peptide showed good reactivity against the original protein. Although the 19-mer adopted the helical secondary structure predicted for the corresponding protein region, antisera against this peptide reacted with the native protein weakly or not at all. Concluding that the poor anti-protein reactivity was due to modification of lysine-containing epitopes by glutaraldehyde conjugation, we used a carrier-free 28-residue peptide presented as a 56-residue disulfide-bonded dimer to model the same region. This peptide, in contrast to the conjugated 19-mer, stimulated the production of IgG antibodies that reacted at high dilution with the authentic protein in immunoblots, ELISA, and radioimmunoprecipitation assays. These data indicate that large carrier-free peptides may be successfully used as immunogens. In addition, our results show that this strategy may greatly improve the ability of conjugation-sensitive peptides to stimulate antibodies reactive with the original protein and therefore has substantial practical application.
人类疟原虫恶性疟原虫大量产生一种75 kDa的蛋白质,该蛋白质存在于裂殖子表面,其功能是感染红细胞。根据编码该蛋白质40%的核苷酸序列,合成了两种长度分别为13个和19个残基的非重叠模型肽,将其与钥孔血蓝蛋白载体偶联,并用于免疫兔子。尽管两种抗血清都有高滴度的抗肽抗体,但只有针对13个残基肽产生的抗血清对原始蛋白质表现出良好的反应性。尽管19肽采用了对应蛋白质区域预测的螺旋二级结构,但针对该肽的抗血清与天然蛋白质反应较弱或根本不反应。由于认为抗蛋白质反应性差是由于戊二醛偶联修饰了含赖氨酸的表位,我们使用了一种无载体的28个残基肽,该肽以56个残基的二硫键连接二聚体形式呈现,来模拟同一区域。与偶联的19肽相比,该肽刺激产生了IgG抗体,这些抗体在免疫印迹、ELISA和放射免疫沉淀试验中以高稀释度与天然蛋白质反应。这些数据表明,大的无载体肽可成功用作免疫原。此外,我们的结果表明,该策略可大大提高对偶联敏感的肽刺激与原始蛋白质反应的抗体的能力,因此具有重要的实际应用价值。